Sr One Capital Management, LLC insider trades: ADARx Pharmaceuticals (ADRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sr One Capital Management, LLC reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | ADRX | ↑ Buy | 592,593 | $17.00 | $10.1M | See Note 5 | Sep 29, 2026 (1d) |
| Sep 28, 2026 | ADRX | ↑ Buy | 592,593 | $17.00 | $10.1M | See Note 2 | Sep 29, 2026 (1d) |
| Sep 28, 2026 | ADRX | ↑ Buy | 414,814 | $17.00 | $7.1M | See Note 3 | Sep 29, 2026 (1d) |
| May 11, 2026 | ODTX | ↑ Buy | 222,222 | $18.00 | $4.0M | See Note 2 | May 11, 2026 (0d) |
| May 11, 2026 | ODTX | ↑ Buy | 200,000 | $18.00 | $3.6M | See Note 12 | May 11, 2026 (0d) |
| May 11, 2026 | ODTX | ↑ Buy | 133,333 | $18.00 | $2.4M | See Note 10 | May 11, 2026 (0d) |
| May 11, 2026 | ODTX | ↓ Sell | 1,065 | $18.00 | $19K | See Note 2 | May 11, 2026 (0d) |
| May 11, 2026 | ODTX | ↓ Sell | 438 | $18.00 | $8K | See Note 12 | May 11, 2026 (0d) |
| May 11, 2026 | ODTX | ↓ Sell | 277 | $18.00 | $5K | See Note 10 | May 11, 2026 (0d) |
| Oct 9, 2025 | ZBIO | ↑ Buy | 63,158 | $19.00 | $1.2M | See Note 2 | Oct 14, 2025 (5d) |
| Oct 9, 2025 | ZBIO | ↑ Buy | 63,157 | $19.00 | $1.2M | See Note 3 | Oct 14, 2025 (5d) |
| Sep 16, 2024 | ZBIO | ↑ Buy | 1,352,942 | $17.00 | $23.0M | See Note 3 | Sep 16, 2024 (0d) |
| Sep 16, 2024 | ZBIO | ↑ Buy | 441,176 | $17.00 | $7.5M | See Note 2 | Sep 16, 2024 (0d) |
| Sep 16, 2024 | ZBIO | ↑ Buy | 441,176 | $17.00 | $7.5M | See Note 4 | Sep 16, 2024 (0d) |
| Nov 27, 2023 | EFTR | ↓ Sell | 430,578 | $0.61 | $261K | See Note 2 | Nov 29, 2023 (2d) |
| Nov 27, 2023 | EFTR | ↓ Sell | 178,585 | $0.61 | $108K | See Note 3 | Nov 29, 2023 (2d) |
| May 11, 2023 | ACLX | ↓ Sell | 638,417 | $45.01 | $28.7M | See Note 2 | May 15, 2023 (4d) |
| May 11, 2023 | ACLX | ↓ Sell | 374,416 | $45.01 | $16.9M | See Note 3 | May 15, 2023 (4d) |
| Dec 20, 2022 | DSGN | ↑ Buy | 900,000 | $8.42 | $7.6M | Direct | Dec 20, 2022 (0d) |
| Feb 8, 2022 | ACLX | ↑ Buy | 1,666,667 | $15.00 | $25.0M | Indirect | Feb 10, 2022 (2d) |
| Mar 30, 2021 | DSGN | ↑ Buy | 250,000 | $20.00 | $5.0M | Direct | Apr 1, 2021 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ADRX insiders
Open-market trades in the last 12 months
About Sr One Capital Management, LLC's insider trades
Sr One Capital Management, LLC is an insider at ADARx Pharmaceuticals (ADRX). Since Mar 30, 2021, it has reported 14 open-market purchases worth $115.2M and 7 sales worth $46.0M on SEC Form 4. In the last 12 months: 6 buys ($37.2M) and 3 sales ($32K).
Its filings also include conversions (5 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.